Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Bruce Neal's publication output changed over time?
ScholarIQpublication output · 2008–2019
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2019.
1
1
1
1
1
1
3
2
1
200820092010201120132015201620172019
What are the most-cited papers on Bruce Neal?
ScholarIQmost cited works
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R. Matthews
New England Journal of Medicine. 20177,831 CitationsOPEN ACCESS
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Mohammad H. Forouzanfar, Ashkan Afshin, Lily Alexander, H Ross Anderson, Zulfiqar A Bhutta, Stan Biryukov, Michael Bräuer, Richard Burnett, Kelly Cercy, Fiona Charlson, Aaron J. Cohen, Lalit Dandona, Kara Estep, Alize J Ferrari, Joseph Frostad, Nancy Fullman, Peter W Gething, William W Godwin, Max Griswold, Simon I Hay, Yohannes Kinfu, Hmwe Hmwe Kyu, Heidi J. Larson, Xiaofeng Liang, Stephen S Lim, Patrick Y Liu, Alan D López, Rafael Lozano, Laurie Marczak, George A. Mensah, Ali H. Mokdad, Maziar Moradi‐Lakeh, Mohsen Naghavi, Bruce Neal, Marissa B Reitsma, Gregory A Roth, Joshua A. Salomon, Patrick J Sur, Theo Vos, Joseph A. Wagner, Haidong Wang, Yi Zhao, Maigeng Zhou, Gunn Marit Aasvang, Amanuel Alemu Abajobir, Kalkidan Hassen Abate, Cristiana Abbafati, Kaja M Abbas, Foad Abd-Allah, Abdishakur M Abdulle, Semaw Ferede Abera, Biju Abraham, Laith J Abu-Raddad, Gebre Yitayih Abyu, Akindele Olupelumi Adebiyi, Isaac Akinkunmi Adedeji, Zanfina Ademi, Arsène Kouablan Adou, José Carmelo Adsuar, Emilie Agardh, Arnav Agarwal, Anurag Agrawal, Aliasghar Ahmad Kiadaliri, Oluremi N Ajala, Tomi F Akinyemiju, Ziyad Al-Aly, Khurshid Alam, Noore K M Alam, Saleh Fahed Aldhahri, Robert William Aldridge, Zewdie Aderaw Alemu, Raghib Ali, Ala'a Alkerwi, François Alla, Peter Allebeck, Ubai Alsharif, Khalid A Altirkawi, Elena Alvarez Martin, Nelson Alvis‐Guzmán, Azmeraw T. Amare, Alemayehu Amberbir, Adeladza Kofi Amegah, Heresh Amini, Walid Ammar, Stephen Marc Amrock, Hjalte H Andersen, Benjamin O. Anderson, Carl Abelardo T. Antonio, Palwasha Anwari, Johan Ärnlöv, Al Artaman, Hamid Asayesh, Rana J Asghar, Reza Assadi, Suleman Atique, Euripide Frinel G Arthur Avokpaho, Ashish Awasthi, Beatriz Paulina Ayala Quintanilla, Peter Azzopardi, Umar Bacha
The Lancet. 20167,819 CitationsOPEN ACCESS
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
The ADVANCE Collaborative Group
New England Journal of Medicine. 20087,445 CitationsOPEN ACCESS
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal, Séverine Bompoint, Hiddo J.L. Heerspink, David M. Charytan, Robert Edwards, Rajiv Agarwal, George L. Bakris, Scott Bull, Christopher P. Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M. Brenner, Kenneth W. Mahaffey
New England Journal of Medicine. 20196,091 CitationsOPEN ACCESS
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent, Martin Landray, Christina Reith, Jonathan Emberson, David C. Wheeler, Charles Tomson, Christoph Wanner, Vera Krane, Alan Cass, Jonathan C. Craig, Bruce Neal, Lixin Jiang, Lai Seong Hooi, Adeera Levin, Lawrence Y. Agodoa, Mike Gaziano, Bertram L. Kasiske, Robert Walker, Ziad A. Massy, Bo Feldt‐Rasmussen, Udom Krairittichai, Vuddidhej Ophascharoensuk, Bengt Fellström, Hallvard Holdaas, Vladimı́r Tesař, Andrzej Więcek, Diederick E. Grobbee, Dick de Zeeuw, Carola Grönhagen‐Riska, Tanaji Dasgupta, David Lewis, William G. Herrington, Marion Mafham, William Majoni, Karl Wallendszus, Richard H. Grimm, Terje Pedersen, Jonathan A. Tobert, Jane Armitage, Alex Baxter, Christopher Bray, Yiping Chen, Zhengming Chen, Michael Hill, Carol Knott, Sarah Parish, David Simpson, Peter Sleight, Alan Young, Rory Collins
The Lancet. 20112,477 Citations
Related on ScholarIQ
UNSW Sydney
Institution
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Paper
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Paper
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
Paper
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Paper
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Paper